CDIOWCardio Diagnostics Holdings Inc. Warrant
0.0175USD+47.06%Mkt Cap: —P/E: —4d ago
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assess…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)14.45K $
Gross Profit14.45K $
Net Income (TTM)-6.50M $
Revenue/Share0.0060 USD
Last Price0.0175 USD
Fiscal Year End—
MR Quarter—
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.01
EPS (TTM)—
EPS (Forward)—
52W Range
0.010119% of range0.0498
52W High0.0498 USD
52W Low0.0101 USD
Profitability
Gross Margin100.00%
Oper. Margin-27950.50%
EBITDA Margin0.00%
Profit Margin-43832.49%
ROE-93.19%
ROA-83.67%
Growth
Revenue Growth-28.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.73M $
CapEx (TTM)419.31K $
FCF Margin-26116.57%
FCF Yield—
Net Debt-5.22M $
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.10
Current Ratio17.15
Quick Ratio15.56
Book Value/Sh2.509 USD
Cash/Share1.888 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float2.83M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta2.22
S&P 52W Chg18.16%
Avg Vol (30d)5.87K
Avg Vol (10d)—
Technical Indicators
RSI (14)51.0
MACD-0.0012
MACD Signal-0.0015
MACD Hist.+0.0003
BB Upper0.0216 USD
BB Middle0.0155 USD
BB Lower0.0094 USD
BB Width78.52%
ATR (14)0.0044 USD
Vol Ratio (20d)1.18x